Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,531 | 195 | 87.8% |
| Travel and Lodging | $453.32 | 2 | 8.8% |
| Education | $173.99 | 2 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,083 | 47 | $0 (2024) |
| Amgen Inc. | $905.50 | 36 | $0 (2024) |
| Smith+Nephew, Inc. | $589.26 | 5 | $0 (2021) |
| PFIZER INC. | $275.50 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $258.41 | 7 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $230.69 | 8 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $179.40 | 10 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $146.94 | 2 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $121.95 | 7 | $0 (2018) |
| GlaxoSmithKline, LLC. | $116.09 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $220.07 | 9 | ABBVIE INC. ($103.85) |
| 2023 | $641.87 | 25 | ABBVIE INC. ($294.25) |
| 2022 | $484.59 | 21 | ABBVIE INC. ($133.01) |
| 2021 | $1,314 | 35 | Smith+Nephew, Inc. ($589.26) |
| 2020 | $502.48 | 22 | Amgen Inc. ($215.48) |
| 2019 | $693.61 | 31 | Amgen Inc. ($206.33) |
| 2018 | $737.20 | 28 | Kowa Pharmaceuticals America, Inc. ($178.37) |
| 2017 | $564.92 | 28 | Amgen Inc. ($154.03) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.46 | General |
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Diabetes Care | ||||||
| 04/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: VACCINES | ||||||
| 11/09/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Diabetes | ||||||
| 10/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: VACCINES | ||||||
| 09/14/2023 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Gastroenterology | ||||||
| 08/23/2023 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: VACCINES | ||||||
| 07/20/2023 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: IMMUNOLOGY | ||||||
| 06/29/2023 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: Vaccines | ||||||
| 06/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Respiratory | ||||||
| 06/08/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: INSOMNIA | ||||||
| 06/05/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,559 | 4,630 | $187,842 | $132,566 |
| 2022 | 33 | 2,828 | 5,145 | $187,839 | $139,076 |
| 2021 | 33 | 2,841 | 5,251 | $184,167 | $133,024 |
| 2020 | 31 | 2,695 | 4,743 | $173,397 | $118,625 |
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 603 | $85,174 | $56,629 | 66.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 111 | 116 | $25,003 | $15,675 | 62.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $12,900 | $11,467 | 88.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $5,780 | $5,343 | 92.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 169 | 461 | $6,809 | $4,771 | 70.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 61 | 61 | $4,575 | $4,384 | 95.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 178 | 535 | $4,467 | $4,177 | 93.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 170 | 440 | $4,814 | $3,348 | 69.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 137 | 203 | $4,764 | $3,341 | 70.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 130 | 225 | $4,212 | $2,952 | 70.1% |
| 86141 | Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | Office | 2023 | 123 | 191 | $3,455 | $2,424 | 70.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 70 | 79 | $3,160 | $2,050 | 64.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 52 | 65 | $2,619 | $1,886 | 72.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 135 | 199 | $2,507 | $1,759 | 70.2% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 64 | 105 | $2,485 | $1,743 | 70.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 60 | 60 | $1,520 | $1,490 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 63 | 126 | $1,709 | $1,200 | 70.2% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 105 | 179 | $1,629 | $1,142 | 70.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 82 | 86 | $1,557 | $948.19 | 60.9% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 131 | 203 | $1,007 | $848.54 | 84.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 122 | 170 | $753.10 | $669.80 | 88.9% |
| 83735 | Magnesium level | Office | 2023 | 79 | 93 | $870.48 | $611.01 | 70.2% |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | Office | 2023 | 14 | 14 | $560.00 | $548.80 | 98.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 30 | 41 | $780.23 | $547.76 | 70.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $532.14 | $521.43 | 98.0% |
About Dr. William Pullen, M.D
Dr. William Pullen, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104977248.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Pullen, M.D has received a total of $5,158 in payments from pharmaceutical and medical device companies, with $220.07 received in 2024. These payments were reported across 199 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,531).
As a Medicare-enrolled provider, Pullen has provided services to 10,923 Medicare beneficiaries, totaling 19,769 services with total Medicare billing of $523,292. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Santa Monica, CA
- Active Since 01/16/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104977248
Products in Payments
- NOVOSTITCH PRO (Device) $589.26
- SYNTHROID (Drug) $556.53
- EVENITY (Biological) $491.60
- Prolia (Biological) $270.47
- Livalo (Drug) $230.69
- Synthroid (Drug) $210.66
- ENTRESTO (Drug) $179.40
- VRAYLAR (Drug) $172.17
- ELIQUIS (Drug) $157.97
- Kerendia (Drug) $146.94
- UBRELVY (Drug) $121.14
- JANUVIA (Drug) $102.24
- SHINGRIX (Biological) $88.73
- MYRBETRIQ (Drug) $84.42
- Edarbi (Drug) $75.02
- TOUJEO (Drug) $67.21
- Victoza (Drug) $61.94
- Repatha (Biological) $61.17
- Vascepa (Drug) $59.47
- PREVNAR 13 (Biological) $57.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Santa Monica
Dr. Gerald Levine, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $158,457
Dr. Rose Lin, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $15,542
Katherine Araque Triana, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $5,502
Dr. Rachael Oxman, Md, Mph, MD, MPH
Endocrinology, Diabetes & Metabolism — Payments: $1,421
Dr. Linda Glaser, M.d., Ph.d, M.D., PH.D
Endocrinology, Diabetes & Metabolism — Payments: $1,199
Janet Winikoff, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $602.99